In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma

SIMPLE SUMMARY: Canine mammary carcinomas (CMC) are associated with poor clinical outcomes and high mortality. Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and tumor progression in many solid tumors, including mammary carcinomas. The goal of this work was to establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardama, Georgina A., Bucci, Paula L., Lemos, Jesús S., Llavona, Candela, Benavente, Micaela A., Hellmén, Eva, Fara, María Laura, Medrano, Eduardo, Spitzer, Eduardo, Demarco, Ignacio A., Sabella, Patricia, Garona, Juan, Alonso, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417262/
https://www.ncbi.nlm.nih.gov/pubmed/37570315
http://dx.doi.org/10.3390/ani13152507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417262/
https://www.ncbi.nlm.nih.gov/pubmed/37570315
http://dx.doi.org/10.3390/ani13152507

Ejemplares similares